{"id":"W4362730611","doi":"10.21037/tlcr-22-723","title":"Adjuvant therapies in stages I–III epidermal growth factor receptor-mutated lung cancer: current and future perspectives","year":2023,"lang":"en","type":"review","venue":"Translational Lung Cancer Research","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"National Cancer Institute; Foundation Medicine; Provincial Health Services Authority; Regeneron Pharmaceuticals; F. Hoffmann-La Roche; Daiichi Sankyo Europe; Sanofi; Chugai Pharmaceutical; Daiichi-Sankyo; Amgen; Pfizer; AstraZeneca; Eli Lilly and Company; Bristol-Myers Squibb","keywords":"Medicine; Lung cancer; Epidermal growth factor receptor; Oncology; Internal medicine; Cancer; Stage (stratigraphy); Chemotherapy; Disease","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003814409,0.0006564069,0.001387692,0.0006554358,0.0003137974,0.001861205,0.001124865,0.002333547,0.00557659],"category_scores_gemma":[0.002423546,0.0002271417,0.001207754,0.0008160826,0.0009540484,0.003073505,0.0007655734,0.003626176,0.001355812],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007115944,"about_ca_system_score_gemma":0.002090705,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007630312,"about_ca_topic_score_gemma":0.003133784,"domain_scores_codex":[0.9994548,0.0002117238,0.00005838402,0.00006777135,0.0001151914,0.00009211904],"domain_scores_gemma":[0.997349,0.001377827,0.0002718241,0.00006761747,0.0005760095,0.0003577169],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.001548311,0.0007531505,0.001482601,0.006728303,0.0001996905,0.0003962737,0.0001407421,0.001280903,0.002313719,0.006999155,0.05192547,0.9262317],"study_design_scores_gemma":[0.0007740008,0.004180708,0.007188667,0.01206558,0.0007763649,0.001948164,0.0009313804,0.002686762,0.001066206,0.02049875,0.9477701,0.0001132451],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001938694,0.9745123,0.0008030024,0.01898347,0.001024998,0.00002254115,0.00008768572,0.00004829653,0.002578948],"genre_scores_gemma":[0.0139032,0.9706088,0.00245841,0.006922452,0.004278795,0.0000960707,0.0002338289,0.00001839101,0.001480061],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.00557659,"threshold_uncertainty_score":0.02017277,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1039491511596937,"score_gpt":0.5075621218298284,"score_spread":0.4036129706701347,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}